{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:29:14Z","timestamp":1785176954190,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.nefro.2015.05.026","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T19:17:05Z","timestamp":1437592625000},"page":"479-486","source":"Crossref","is-referenced-by-count":8,"title":["Caracter\u00edsticas cl\u00ednicas, evoluci\u00f3n y pron\u00f3stico de la nefropat\u00eda membranosa idiop\u00e1tica en funci\u00f3n de la presencia de anticuerpos contra el receptor tipo M de la fosfolipasa A2"],"prefix":"10.1016","volume":"35","author":[{"given":"El\u00edas","family":"Jatem Escalante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Segarra Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Carnicer C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Adoraci\u00f3n","family":"Mart\u00edn-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Salcedo Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Ostos Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Agraz Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nefro.2015.05.026_bib0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.1987.179","article-title":"Epidemiology of idiopathic glomerular disease: A prospective study","volume":"32","author":"Tiebosch","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2015.05.026_bib0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1196\/annals.1423.060","article-title":"Fetomaternal alloimmunization with antenatal glomerulopathies","volume":"1110","author":"Debiec","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.nefro.2015.05.026_bib0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMe0903343","article-title":"Human idiopathic membranous nephropathy \u2014 a mystery solved?","volume":"361","author":"Glassock","year":"2009","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.nefro.2015.05.026_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.nefro.2015.05.026_bib0150","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"10.1016\/j.nefro.2015.05.026_bib0155","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"10.1016\/j.nefro.2015.05.026_bib0160","doi-asserted-by":"crossref","first-page":"e62151","DOI":"10.1371\/journal.pone.0062151","article-title":"Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy","volume":"8","author":"Oh","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.nefro.2015.05.026_bib0165","first-page":"33A","article-title":"Association of anti-PLA2R with disease activity and outcome in idiopathic membranous nephropathy","volume":"22","author":"Kanigicherla","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"10.1016\/j.nefro.2015.05.026_bib0170","first-page":"491","article-title":"Evoluci\u00f3n del t\u00edtulo de anticuerpos contra el receptor tipo M de la fosfolipasa A2 y respuesta cl\u00ednica en pacientes con nefropat\u00eda membranosa idiop\u00e1tica tratados con tacrolimus","volume":"34","author":"Segarra-Medrano","year":"2014","journal-title":"Nefrologia."},{"issue":"1","key":"10.1016\/j.nefro.2015.05.026_bib0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/1354750X.2014.993708","article-title":"Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with 2 different immunosuppression regimens","volume":"20","author":"Segarra Medrano","year":"2015","journal-title":"Biomarkers"},{"key":"10.1016\/j.nefro.2015.05.026_bib0180","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2215\/CJN.10471013","article-title":"Association of anti-PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy","volume":"9","author":"Bech","year":"2014","journal-title":"CJASN."},{"issue":"0","key":"10.1016\/j.nefro.2015.05.026_bib0185","first-page":"1","article-title":"An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis","author":"Hoxha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.nefro.2015.05.026_bib0190","first-page":"353","article-title":"Prevalencia, valor diagn\u00f3stico y caracter\u00edsticas cl\u00ednicas asociadas a la presencia de niveles circulantes y dep\u00f3sitos renales de anticuerpos contra el receptor tipo M de la fosfolipasa A2 en nefropat\u00eda membranosa idiop\u00e1tica","volume":"34","author":"Segarra","year":"2014","journal-title":"Nefrologia."},{"issue":"6","key":"10.1016\/j.nefro.2015.05.026_bib0195","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"10.1016\/j.nefro.2015.05.026_bib0200","first-page":"109","article-title":"Anti-PLA2R antibodies in membranous nephropathy: Ready for routine clinical practice?","volume":"70","author":"Hofstra","year":"2012","journal-title":"Neth J Med."},{"key":"10.1016\/j.nefro.2015.05.026_bib0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.04160413","article-title":"Glomerular diseases: Membranous nephropathy - A modern view","volume":"9","author":"Ponticelli","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.05.026_bib0210","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.05.026_bib0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.05.026_bib0220","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Eng J Med."},{"key":"10.1016\/j.nefro.2015.05.026_bib0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.nefro.2015.05.026_bib0230","first-page":"565","article-title":"Confidence interval estimates of an index of quality performance based on logistic regression models","volume":"106","author":"Hosmer","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.nefro.2015.05.026_bib0235","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2215\/CJN.06041108","article-title":"Successful treatment of membranous glomerulonephritis withrituximab in calcineurin inhibitor-dependent patients","volume":"4","author":"Segarra","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.05.026_bib0240","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2015.05.026_bib0245","first-page":"1","article-title":"Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment","volume":"0","author":"Polanco","year":"2011","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"10.1016\/j.nefro.2015.05.026_bib0250","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T18:58:42Z","timestamp":1537469922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699515000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0211699515000636"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2015.05.026","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}